Multiple sclerosis mortality in New Zealand: a nationwide prospective study.
Journal of neurology, neurosurgery, and psychiatry(2023)
Abstract
New Zealanders with MS have a median survival age 7.2 years lower than the general population and twice the mortality risk. The survival gap was greater for progressive-onset disease and for those with an early age of onset.
MoreTranslated text
Key words
epidemiology,multiple sclerosis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined